Literature DB >> 5922886

Propranolol in hypertension.

F A Richards.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5922886     DOI: 10.1016/0002-9149(66)90058-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  16 in total

Review 1.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

2.  [Modification of sympathetic hyperactivity by drugs. Short-term pharmacologic experiments using parasympathomimetics and beta-receptor blockaders in humans].

Authors:  A W von Eiff; A Czernik; K Zanders
Journal:  Klin Wochenschr       Date:  1969-07-01

Review 3.  [Adrenergic alpha and beta receptors and their specific inhibitors].

Authors:  E Muscholl; K H Rahn
Journal:  Klin Wochenschr       Date:  1968-02-01

4.  Propranolol in the office treatment of angina pectoris.

Authors:  B J Harley; R O Davies
Journal:  Can Med Assoc J       Date:  1968-09-28       Impact factor: 8.262

5.  Propranolol and polythiazide in treatment of hypertension.

Authors:  E T O'Brien; J MacKinnon
Journal:  Br Heart J       Date:  1972-10

6.  Three cases of severe hypertension controlled with propranolol.

Authors:  B N Prichard
Journal:  Proc R Soc Med       Date:  1968-05

7.  Propranolol in hypertension.

Authors:  S N Tewari; R H Grant
Journal:  Postgrad Med J       Date:  1968-07       Impact factor: 2.401

8.  Serum enzymes and propranolol.

Authors:  R Wilkinson; J A Luetscher; R H Goldman
Journal:  Br Med J       Date:  1971-05-01

9.  [Effects of acute and chronic diminution of cardiac output on blood pressure in early hypertention. Hemodynamic alterations after beta-receptor blockade].

Authors:  M Molzahn; T Dissmann; R Gotzen; F W Lohmann
Journal:  Klin Wochenschr       Date:  1971-04-15

10.  Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.

Authors:  M Motolese; G Muiesan; A Colombi
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.